肯尼亚病毒抑制的HIV感染者全身炎症水平仍高于HIV阴性者
本研究为肯尼亚Kisumu县医院成人横断面研究,纳入286例HIV感染者与277例HIV阴性者,检测IL-1β、IL-6、TNF-α与hsCRP。在校正心血管危险因素后,病毒抑制的HIV感染者上述炎症标志物平均水平仍显著高于HIV阴性者。
要点
- 病毒抑制的HIV感染者IL-6、IL-1β、TNF-α、hsCRP平均水平均高于HIV阴性者
- 该差异独立于传统心血管疾病危险因素
- 男性、年龄较大与肥胖与更高炎症标志物浓度相关
核心结论
- 病毒抑制的HIV感染者仍存在更高水平的全身炎症生物标志物,且独立于传统心血管疾病危险因素。
研究设计与样本
- 肯尼亚Kisumu县医院成人横断面研究,纳入286例HIV感染者与277例HIV阴性者,采用多重免疫分析检测炎症标志物。
主要发现
- HIV感染者平均IL-6浓度高51%(P < .001),IL-1β高39%(P = .005),TNF-α高40%(P < .001),hsCRP高27%(P = .008),均独立于心血管疾病危险因素。
- HIV感染者抗逆转录病毒治疗中位时长8年(四分位距4-10),96%达到病毒抑制。
- 男性、年龄较大与肥胖与更高炎症标志物浓度相关。
- 仅在HIV感染者中,病毒载量≥1000 copies/mL与更高TNF-α水平相关(P = .013)。
临床怎么用
- 对病毒抑制的HIV感染者仍应关注残余炎症与心血管风险,不能仅以病毒抑制作为风险控制充分的依据。
局限性
- 横断面设计无法判断炎症标志物与未来心血管事件的因果关系,需进一步纵向研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Systemic inflammation independently predicts future cardiovascular events and is associated with a 2-fold increase in cardiovascular disease (CVD) risk among persons living with human immunodeficiency virus (PLHIV). We examined the association between inflammatory markers, HIV status, and traditional CVD risk factors. METHODS: We conducted a cross-sectional study of Kenyan adults with and without HIV seeking care at Kisumu County Hospital. Using a multiplex immunoassay, we measured interleukin (IL) 1β, IL-6, tumor necrosis factor α (TNF-α), and high-sensitivity C-reactive protein (hsCRP) concentrations. We compared inflammatory marker concentrations by HIV status using the Wilcoxon rank-sum test. Multivariable linear regression was used to evaluate associations between inflammatory biomarkers and HIV status, adjusting for CVD risk factors. RESULTS: We enrolled 286 PLHIV and 277 HIV-negative participants. Median duration of antiretroviral therapy for PLHIV was 8 years (interquartile range, 4-10) and 96% were virally suppressed. PLHIV had a 51% higher mean IL-6 concentration (P < .001), 39% higher mean IL-1β (P = .005), 40% higher mean TNF-α (P < .001), and 27% higher mean hsCRP (P = .008) compared with HIV-negative participants, independent of CVD risk factors. Male sex, older age, and obesity were associated with higher concentrations of inflammatory markers. Restricting to PLHIV, viral load of ≥1000 copies/mL was associated with higher TNF-α levels (P = .013). CONCLUSIONS: We found higher levels of systemic inflammatory biomarkers among PLHIV who were virally suppressed, and this was independent of traditional CVD risk factors. Further longitudinal analyses to determine whether these inflammatory markers predict future CVD events, and are possible therapeutic targets among PLHIV, are warranted.
引用
- Masyuko SJ, Page ST, Polyak SJ, et al. Human Immunodeficiency Virus Is Associated With Higher Levels of Systemic Inflammation Among Kenyan Adults Despite Viral Suppression. Clin Infect Dis. 2021. PMID: 33313687. doi:10.1093/cid/ciaa1650
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。